Terms: = Skin cancer AND IDH2, P48735, 3418, ENSG00000182054, IDHM, mNADP-IDH, IDH, IDP, ICD-M
32 results:
1. [Blastic plasmacytoid dendritic cell tumor treated with DVT regimen: a case report and literature review].
Shi J; Xu N; Niu Y; Jia SX; Yang CM; Fang MY
Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):86-89. PubMed ID: 38527844
[TBL] [Abstract] [Full Text] [Related]
2. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
3. Identification of co-expressed gene networks promoting CD8
Zhang C; Xiao J; Fa L; Jiang F; Jiang H; Zhou L; Xu Z
BMC Ophthalmol; 2023 Aug; 23(1):354. PubMed ID: 37563735
[TBL] [Abstract] [Full Text] [Related]
4. CD8/PD-L1 immunohistochemical reactivity and gene alterations in cutaneous squamous cell carcinoma.
Nishida H; Kondo Y; Kusaba T; Kawamura K; Oyama Y; Daa T
PLoS One; 2023; 18(2):e0281647. PubMed ID: 36780540
[TBL] [Abstract] [Full Text] [Related]
5. PLEKHA4 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Glioma.
Zhang W; Li L; Bian PP; Luo QP; Xiong ZT
Biomed Res Int; 2023; 2023():4504474. PubMed ID: 36714030
[TBL] [Abstract] [Full Text] [Related]
6. Tumour treating fields in glioblastoma: is the treatment tolerable, effective, and practical in UK patients?
Olubajo F; Thorpe A; Davis C; Sinha R; Crofton A; Mills SJ; Williams M; Jenkinson MD; Price SJ; Watts C; Brodbelt AR
Br J Neurosurg; 2022 Dec; 36(6):770-776. PubMed ID: 35200077
[TBL] [Abstract] [Full Text] [Related]
7. Granulomatous Dermatitis Heralding Myelodisplastic/Myeloproliferative Neoplasms. Neoplastic or Reactive Cells? A Study of 2 Cases.
Prieto-Torres L; Santonja C; Chamizo C; García-Gil MF; Lezcano V; Arranz-Sánchez DM; Rodríguez-Pinilla SM; Azaceta G; García-García M
Am J Dermatopathol; 2022 Jun; 44(6):456-460. PubMed ID: 35170471
[TBL] [Abstract] [Full Text] [Related]
8. Bilateral periorbital leukemia cutis presenting as suspected cellulitis.
Gupta L; Levoska MA; Sharma T; Honda K; Prendes MA
Orbit; 2022 Aug; 41(4):506-508. PubMed ID: 33682591
[TBL] [Abstract] [Full Text] [Related]
9. Glioblastoma and malignant melanoma: Serendipitous or anticipated association?
Yang K; Stein TD; Huber BR; Sartor EA; Rachlin JR; Mahalingam M
Neuropathology; 2021 Feb; 41(1):65-71. PubMed ID: 33103282
[TBL] [Abstract] [Full Text] [Related]
10. A genomic survey of sarcomas on sun-exposed skin reveals distinctive candidate drivers and potentially targetable mutations.
Miller TI; Zoumberos NA; Johnson B; Rhodes DR; Tomlins SA; Chan MP; Andea AA; Lucas DR; McHugh JB; Smith N; Harms KL; Brewer C; Saleh J; Patel RM; Harms PW
Hum Pathol; 2020 Aug; 102():60-69. PubMed ID: 32540221
[TBL] [Abstract] [Full Text] [Related]
11. Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders: A Clinical, Pathologic, and Molecular Study of 60 Cases Presenting With a Single Lesion: A Multicenter Study of the French Cutaneous Lymphoma Study Group.
Beltzung F; Ortonne N; Pelletier L; Beylot-Barry M; Ingen-Housz-Oro S; Franck F; Pereira B; Godfraind C; Delfau MH; D'Incan M; Vergier B
Am J Surg Pathol; 2020 Jul; 44(7):862-872. PubMed ID: 32271188
[TBL] [Abstract] [Full Text] [Related]
12. The cancer driver genes idh1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
13. [New molecular pathological strategies for malignant iris tumors].
Kakkassery V; Jünemann AM; Scheef BO; Grisanti S; Heindl LM
Ophthalmologe; 2019 Apr; 116(4):324-331. PubMed ID: 30623224
[TBL] [Abstract] [Full Text] [Related]
14. An insight into the molecular genetics of a uveal melanoma patient cohort.
Kennedy S; Rice M; Toomey S; Horgan N; Hennessey BT; Larkin A
J Cancer Res Clin Oncol; 2018 Oct; 144(10):1861-1868. PubMed ID: 30008023
[TBL] [Abstract] [Full Text] [Related]
15. Isocitrate dehydrogenase 1 mutations in melanoma frequently co-occur with NRAS mutations.
Linos K; Tafe LJ
Histopathology; 2018 Dec; 73(6):963-968. PubMed ID: 30003571
[TBL] [Abstract] [Full Text] [Related]
16. Altered epigenetic pathways and cell cycle dysregulation in healthy appearing skin of patients with koebnerized squamous cell carcinomas following skin surgery.
Gambichler T; Rüddel I; Hessam S; Bechara FG; Stockfleth E; Schmitz L
J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):1485-1491. PubMed ID: 29478287
[TBL] [Abstract] [Full Text] [Related]
17. Expression of TFH Markers and Detection of RHOA p.G17V and idh2 p.R172K/S Mutations in Cutaneous Localizations of Angioimmunoblastic T-Cell Lymphomas.
Leclaire Alirkilicarslan A; Dupuy A; Pujals A; Parrens M; Vergier B; Robson A; Delfau-Larue MH; Ingen-Housz-Oro S; Chosidow O; Haioun C; Beylot-Barry M; Merlio JP; Copie-Bergman C; Gaulard P; Ortonne N
Am J Surg Pathol; 2017 Dec; 41(12):1581-1592. PubMed ID: 28945625
[TBL] [Abstract] [Full Text] [Related]
18. A systems approach reveals distinct metabolic strategies among the NCI-60 cancer cell lines.
Aurich MK; Fleming RMT; Thiele I
PLoS Comput Biol; 2017 Aug; 13(8):e1005698. PubMed ID: 28806730
[TBL] [Abstract] [Full Text] [Related]
19. Concomitant Cutaneous Langerhans Cell Hystiocytosis and Leukemia Cutis.
Pina-Oviedo S; Torres-Cabala CA; Miranda RN; Tetzlaff MT; Singh S; Rapini RP; Prieto VG; Aung PP
Am J Dermatopathol; 2017 May; 39(5):388-392. PubMed ID: 27759701
[TBL] [Abstract] [Full Text] [Related]
20. Mutational status of idh1 in uveal melanoma.
Cimino PJ; Kung Y; Warrick JI; Chang SH; Keene CD
Exp Mol Pathol; 2016 Jun; 100(3):476-81. PubMed ID: 27155448
[TBL] [Abstract] [Full Text] [Related]
[Next]
